| PJERX | RWIAX | PJERX / RWIAX | |
| Total Expense Ratio | 1.47 | 1.51 | 97% |
| Annual Report Gross Expense Ratio | 1.72 | 1.51 | 114% |
| Fund Existence | 15 years | 24 years | - |
| Gain YTD | 18.981 | 15.218 | 125% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | N/A | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 881M | 160B | 1% |
| Annual Yield % from dividends | 1.46 | 0.73 | 199% |
| Returns for 1 year | 26.62 | 20.85 | 128% |
| Returns for 3 years | 49.66 | 49.70 | 100% |
| Returns for 5 years | 33.32 | 31.19 | 107% |
| Returns for 10 years | 40.48 | 102.34 | 40% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CSHZX | 13.70 | 0.15 | +1.11% |
| NYLI Cushing® MLP Premier Class I | |||
| FSMAX | 116.33 | N/A | N/A |
| Fidelity Extended Market Index | |||
| ACIZX | 66.86 | N/A | N/A |
| Alger Capital Appreciation Instl Z-2 | |||
| BIPIX | 80.88 | N/A | N/A |
| ProFunds Biotechnology UltraSector Inv | |||
| TASVX | 22.54 | N/A | N/A |
| PGIM Quant Solutions Small-Cap Val Z | |||